EP1549391B1 - Implantable medical device - Google Patents
Implantable medical device Download PDFInfo
- Publication number
- EP1549391B1 EP1549391B1 EP03797759A EP03797759A EP1549391B1 EP 1549391 B1 EP1549391 B1 EP 1549391B1 EP 03797759 A EP03797759 A EP 03797759A EP 03797759 A EP03797759 A EP 03797759A EP 1549391 B1 EP1549391 B1 EP 1549391B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- medical device
- time period
- specified time
- mode
- detecting means
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000004913 activation Effects 0.000 claims abstract description 30
- 238000001514 detection method Methods 0.000 claims description 25
- 230000009849 deactivation Effects 0.000 claims description 5
- 230000011664 signaling Effects 0.000 claims description 4
- 230000003287 optical effect Effects 0.000 claims description 2
- 238000001994 activation Methods 0.000 description 19
- 230000004044 response Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37252—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
Definitions
- the present invention relates to an implantable medical device according to the preamble of the independent claim.
- a magnet to change the pacemaker to a predetermined test mode, for indication of e.g. battery condition.
- Other predetermined modes may for instance be threshold tests or diagnostic data storage etc.
- a magnetically strong test magnet is held at the skin of the patient in order to activate a detector.
- An activation of the detector results in a "magnet ON" detection which in turn results in a change to the predetermined mode.
- a pacemaker is for instance disclosed in US 4,390,020 .
- US-5,722,998 discloses an implantable medical device including a GMR sensor that inter alia is used to detect the presence of a magnetic field from a permanent magnet. In that case the sensor is used to revert the operation of the implantable device to a magnet mode (also referred to as safe mode) of operation in which a predetermined, typically asynchronous, ventricular pacing rate is issued.
- a GMR sensor that inter alia is used to detect the presence of a magnetic field from a permanent magnet.
- the sensor is used to revert the operation of the implantable device to a magnet mode (also referred to as safe mode) of operation in which a predetermined, typically asynchronous, ventricular pacing rate is issued.
- the problem to be solved by the present invention thus is to provide an IPG which is more flexible in regard of the magnet mode than the prior art discussed above. It should be noted that, although the above prior art description is based on magnetic signal detectors, the invention should also encompass other signal detectors allowing a simple yes/no or on/off response to a signal
- the present invention offers the opportunity to customize the behaviour of an implantable medical device during a defined time period.
- the new usage of applying the test magnet is that the magnet response is not the normal specified test behaviour during a specific period.
- the function during magnet application will instead be what specifically has been ordered.
- the specific period has a limited length that is determined during a programming session. After that specific period has passed, the normal test behaviour will occur at magnet application.
- a device e.g. an implantable pacemaker
- the new feature is that after a predefined, limited time period the specific behaviour will end and the device will revert to the normal magnet response behaviour.
- Figure 1 shows a schematic block diagram of the present invention including an implantable medical device 2 adapted to be operated in a normal mode of operation and in at least one other mode of operation and provided with a signal detecting means 4 responsive of an external activation 6 from an external activation means 8.
- the signal detecting means 4 is preferably a magnetic sensor responsive of an externally generated magnetic field.
- the magnetic sensor may be e.g. a reed element, a GMR sensor or a Hall sensor.
- the medical device is provided with a special timing means 10 adapted to be programmed with a specified time period (as indicated with the arrow 12).
- the programming is performed by an external programming unit 14 outside the body that communicates, e.g. via radio signals, with a communication means 16 in the medical device.
- the medical device further includes a control means 18 responsive for the overall control of the function of the medical device.
- the different parts of the medical device are energized by a battery means (not shown).
- the medical device is an implantable heart stimulator, e.g. a pacemaker, a cardioverter or a defibrillator.
- the medical device also includes a therapy means (not shown) adapted to generate a specific therapy.
- the medical device is adapted to enter a predefined special mode of operation if an external activation is detected by the signal detecting means 4 during the specified time period, and the device is adapted to enter a normal test mode of operation if an external activation is detected by said signal detecting means 4 outside the specified time period.
- a normal mode of operation may be a DDD mode, i.e. a dual chamber pacemaker provided with pacing and sensing capabilities in both heart chambers and having an inhibiting and triggering response to sensing.
- an external activation means 8 preferably a magnet
- the mode of operation may be changed to a normal test mode.
- the normal test mode may be for example for indication of the battery condition, for initiating a test of the stimulation threshold or to start ECG recordings or other diagnostic data storage.
- the predefined special mode of operation is a safe operating mode where typically an asynchronous, ventricular pacing rate is issued.
- the parameters used to define the safe operating mode and the specified time period are preferably programmed and communicated to the communication means during one and the same programming session before a medical intervention.
- the specified time period may in principle have any feasible value, but a practical upper limit may be a week and a lower limit may be in the order of a few hours, e.g. 1 hour.
- FIGS 2-5 show time diagrams of three different scenarios that illustrate different aspects of the present invention.
- Each of the figures 2-5 shows, from above, the detection signal in the normal state (low) or in the detection state (high), and below follows horizontal bars representing the special time period, the normal mode of operation, the normal test mode of operation and the special mode of operation.
- the signal detecting means 4 is adapted to generate a detection signal 22 (see figure 1 ) that is set in a detection state upon the detection of an external activation and remains in the detection state as long as the external activation persists.
- the detection signal is normally in a normal state.
- the specified time period is normally much longer than the duration for the external activation.
- the present invention is illustrated.
- the patient is scheduled for e.g. a surgical operation involving some kind of procedure that could affect the function of the patient's pacemaker.
- the patient first visits her cardiologist, e.g. the same day as the operation or some day before, that determines a proper safe parameter settings, being the special mode of operation, for the pacemaker during the surgical operation and also determines the special time period this setting should be used when an external activation is detected by the signal detecting means 4.
- the cardiologist programs the pacemaker with the determined parameter settings and the special time period by means of the external programming means.
- the special time period preferably starts to run immediately after the special timing means is programmed but could also, alternatively, starts to run a predetermined time after the programming is performed. This alternative situation could happen if the patient visits the cardiologist on a Friday and the planned surgical operation is during the next week (Monday to Friday). The patient then may undergo the planned surgical operation without the presence of the cardiologist.
- the surgeon/physician places a magnet on the skin outside the pacemaker that enters the safe special mode of operation and remains in that mode as long as the magnetic field is detected by the signal detecting means 4.
- This is seen in figure 2 as the horizontal bar representing the special mode which is activated when the detection signal is in its detection state. When the magnet is taken away the pacemaker returns to the normal mode of operation.
- the duration of the detection signal in the detection state is, for illustrative purposes, much longer compared to the duration of the special time period than in most situations when invention is used in reality.
- Figure 3 illustrates the behaviour of the medical device if no special time period has been programmed, i.e. the normal test mode is activated when an external activation (the detection signal in a detection state) is applied.
- Figure 4 illustrates the unusual situation that occurs if the special time period runs out before the external activation is terminated. In that case the medical device remains in the special mode of operation entered during the specified time period even if the specified time period runs out, as long as the detection signal is in the detection state.
- Figure 5 illustrates a combination of the different scenarios shown in figures 2-4 where a number of (three) activations are made, two within the duration of the special time period and one outside.
- the external activation are radio signals generated by the external activation means that may be included in the external programming unit.
- the radio signals being the external activation then includes a signalling message in the form of e.g. radio pulses coded to be interpreted as activation, i.e. the detection signal is set in a detection state.
- the special mode of operation is ended by an external deactivation including a signalling message in the form of e.g. radio pulses coded to mean deactivation.
- the external activation has the form of light signals, either as continuous light or as activation and deactivation light pulses.
- the signal detecting means 4 is in this embodiment any suitable optical sensor.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
- The present invention relates to an implantable medical device according to the preamble of the independent claim.
- It is known in the art of implantable heart stimulators or pulse generator to use a magnet to change the pacemaker to a predetermined test mode, for indication of e.g. battery condition. Other predetermined modes may for instance be threshold tests or diagnostic data storage etc. When such a test is performed a magnetically strong test magnet is held at the skin of the patient in order to activate a detector. An activation of the detector results in a "magnet ON" detection which in turn results in a change to the predetermined mode. Such a pacemaker is for instance disclosed in
US 4,390,020 . -
US-5,722,998 discloses an implantable medical device including a GMR sensor that inter alia is used to detect the presence of a magnetic field from a permanent magnet. In that case the sensor is used to revert the operation of the implantable device to a magnet mode (also referred to as safe mode) of operation in which a predetermined, typically asynchronous, ventricular pacing rate is issued. - However, some medical interventions might interfere with the function of an implantable pulse generator such as a pacemaker. Examples are electrosurgery, diathermal treatment etc. In these cases one possibility is to program the IPG into a safe mode during the entire intervention. The device according to the '998 patent of course allows this, but at the cost of not allowing the device to be provided with a magnet test mode, since the magnet mode is reserved for the safe mode. The device according to the '020 patent does not allow a safe mode, but does allow the magnet test mode. To obtain a safe mode the device according to the '020 patent the device would have to be extensively reprogrammed by a cardiologist both before and after the medical intervention.
- The problem to be solved by the present invention thus is to provide an IPG which is more flexible in regard of the magnet mode than the prior art discussed above. It should be noted that, although the above prior art description is based on magnetic signal detectors, the invention should also encompass other signal detectors allowing a simple yes/no or on/off response to a signal
- The above-mentioned object is achieved by the present invention as set forth in the independent claim.
- Preferred embodiments are set forth in the dependent claims.
- The present invention offers the opportunity to customize the behaviour of an implantable medical device during a defined time period.
- The new usage of applying the test magnet is that the magnet response is not the normal specified test behaviour during a specific period. The function during magnet application will instead be what specifically has been ordered. The specific period has a limited length that is determined during a programming session. After that specific period has passed, the normal test behaviour will occur at magnet application.
- The feature that a device, e.g. an implantable pacemaker, may have different programmed magnet response is not new.
The new feature is that after a predefined, limited time period the specific behaviour will end and the device will revert to the normal magnet response behaviour. -
-
Figure 1 shows a schematic block diagram of the present invention. -
Figures 2-5 show time diagrams of three different scenarios that illustrate different aspects of the present invention. -
Figure 1 shows a schematic block diagram of the present invention including an implantablemedical device 2 adapted to be operated in a normal mode of operation and in at least one other mode of operation and provided with a signal detecting means 4 responsive of anexternal activation 6 from an external activation means 8. The signal detecting means 4 is preferably a magnetic sensor responsive of an externally generated magnetic field. The magnetic sensor may be e.g. a reed element, a GMR sensor or a Hall sensor. - The medical device is provided with a special timing means 10 adapted to be programmed with a specified time period (as indicated with the arrow 12). The programming is performed by an
external programming unit 14 outside the body that communicates, e.g. via radio signals, with a communication means 16 in the medical device.
The medical device further includes a control means 18 responsive for the overall control of the function of the medical device. The different parts of the medical device are energized by a battery means (not shown). - According to a preferred embodiment of the present invention the medical device is an implantable heart stimulator, e.g. a pacemaker, a cardioverter or a defibrillator. In this case the medical device also includes a therapy means (not shown) adapted to generate a specific therapy.
- The medical device is adapted to enter a predefined special mode of operation if an external activation is detected by the signal detecting means 4 during the specified time period, and the device is adapted to enter a normal test mode of operation if an external activation is detected by said signal detecting means 4 outside the specified time period.
- In the preferred embodiment where the medical device is a pacemaker a normal mode of operation may be a DDD mode, i.e. a dual chamber pacemaker provided with pacing and sensing capabilities in both heart chambers and having an inhibiting and triggering response to sensing.
- If an external activation means 8, preferably a magnet, is held at the
skin 20 close to the medical device the mode of operation may be changed to a normal test mode.
As indicated above the normal test mode may be for example for indication of the battery condition, for initiating a test of the stimulation threshold or to start ECG recordings or other diagnostic data storage. - The predefined special mode of operation is a safe operating mode where typically an asynchronous, ventricular pacing rate is issued. The parameters used to define the safe operating mode and the specified time period are preferably programmed and communicated to the communication means during one and the same programming session before a medical intervention.
- The specified time period may in principle have any feasible value, but a practical upper limit may be a week and a lower limit may be in the order of a few hours, e.g. 1 hour.
-
Figures 2-5 show time diagrams of three different scenarios that illustrate different aspects of the present invention.
Each of thefigures 2-5 shows, from above, the detection signal in the normal state (low) or in the detection state (high), and below follows horizontal bars representing the special time period, the normal mode of operation, the normal test mode of operation and the special mode of operation. - The signal detecting means 4 is adapted to generate a detection signal 22 (see
figure 1 ) that is set in a detection state upon the detection of an external activation and remains in the detection state as long as the external activation persists. The detection signal is normally in a normal state.
The specified time period is normally much longer than the duration for the external activation. - In
figure 2 the present invention is illustrated.
In a typical situation where the present invention is applicable the patient is scheduled for e.g. a surgical operation involving some kind of procedure that could affect the function of the patient's pacemaker. The patient first visits her cardiologist, e.g. the same day as the operation or some day before, that determines a proper safe parameter settings, being the special mode of operation, for the pacemaker during the surgical operation and also determines the special time period this setting should be used when an external activation is detected by the signal detecting means 4. The cardiologist then programs the pacemaker with the determined parameter settings and the special time period by means of the external programming means.
The special time period preferably starts to run immediately after the special timing means is programmed but could also, alternatively, starts to run a predetermined time after the programming is performed. This alternative situation could happen if the patient visits the cardiologist on a Friday and the planned surgical operation is during the next week (Monday to Friday).
The patient then may undergo the planned surgical operation without the presence of the cardiologist. During the critical part(s) of the operation the surgeon/physician places a magnet on the skin outside the pacemaker that enters the safe special mode of operation and remains in that mode as long as the magnetic field is detected by the signal detecting means 4. This is seen infigure 2 as the horizontal bar representing the special mode which is activated when the detection signal is in its detection state.
When the magnet is taken away the pacemaker returns to the normal mode of operation. In the figure the duration of the detection signal in the detection state is, for illustrative purposes, much longer compared to the duration of the special time period than in most situations when invention is used in reality. -
Figure 3 illustrates the behaviour of the medical device if no special time period has been programmed, i.e. the normal test mode is activated when an external activation (the detection signal in a detection state) is applied. -
Figure 4 illustrates the unusual situation that occurs if the special time period runs out before the external activation is terminated. In that case the medical device remains in the special mode of operation entered during the specified time period even if the specified time period runs out, as long as the detection signal is in the detection state. -
Figure 5 illustrates a combination of the different scenarios shown infigures 2-4 where a number of (three) activations are made, two within the duration of the special time period and one outside. - According to an alternative embodiment of the present invention the external activation are radio signals generated by the external activation means that may be included in the external programming unit. The radio signals being the external activation then includes a signalling message in the form of e.g. radio pulses coded to be interpreted as activation, i.e. the detection signal is set in a detection state.
In this alternative embodiment the special mode of operation is ended by an external deactivation including a signalling message in the form of e.g. radio pulses coded to mean deactivation. - According to another alternative embodiment the external activation has the form of light signals, either as continuous light or as activation and deactivation light pulses. The
signal detecting means 4 is in this embodiment any suitable optical sensor. - The present invention is not limited to the above-described preferred embodiments. Various alternatives, modifications and equivalents may be used. Therefore, the above embodiments should not be taken as limiting the scope of the invention, which is defined by the appending claims.
Claims (15)
- Implantable medical device (2) adapted to be operated in a normal mode of operation and in at least one other mode of operation and provided with a signal detecting means (4) responsive of an external activation (6), characterized in that said medical device is provided with a special timing means (10) adapted to be programmed with a specified time period, in which time period the device is adapted to enter said one other mode of operation being a predefined special mode of operation if an external activation is detected by said signal detecting means (4) during said specified time period, and that the device is adapted to enter a normal test mode of operation if an external activation is detected by said signal detecting means (4) outside said specified time period.
- Medical device according to claim 1, characterized in that said predefined special mode of operation is a safe operating mode and programmed simultaneously as the specified time period is programmed.
- Medical device according to claim 1, characterized in that said specified time period is less than 5 days.
- Medical device according to claim 3, characterized in that said specified time period is less than 5 hours.
- Medical device according to claim 1, characterized in that said signal detecting means (4) is adapted to generate a detection signal that is set in a detection state upon the detection of an external activation.
- Medical device according to claim 5, characterized in that said detection signal is in said detection state as long as the external activation persists.
- Medical device according to claim 6, characterized in that the medical device remains in the special mode of operation entered during the specified time period even if the specified time period runs out, as long as the detection signal is in the detection state.
- Medical device according to claim 1, characterized in that said specified time period starts to run when the programming is performed.
- Medical device according to claim 1, characterized in that said specified time period starts to run a predefined period after the programming is performed.
- Medical device according to claim 1, characterized in that said signal detecting means (4) is a magnetic sensor responsive of an external magnetic field.
- Medical device according to claim 1, characterized in that said signal detecting means (4) is a optical sensor responsive to light.
- Medical device according to claim 1, characterized in that said external activation are radio signals generated by an external programming means.
- Medical device according to claim 12, characterized in that said external activation includes a signalling message in the form of electromagnetic pulses coded to mean activation.
- Medical device according to claim 13, characterized in that said special mode of operation is ended by an external deactivation including a signalling message in the form of electromagnetic pulses coded to mean deactivation.
- Medical device according to claim 1, characterized in that said medical device is an implantable heart stimulator.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202803 | 2002-09-23 | ||
SE0202803A SE0202803D0 (en) | 2002-09-23 | 2002-09-23 | Implantable medical device |
PCT/SE2003/001082 WO2004026395A1 (en) | 2002-09-23 | 2003-06-23 | Implantable medical device |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1549391A1 EP1549391A1 (en) | 2005-07-06 |
EP1549391B1 true EP1549391B1 (en) | 2009-04-08 |
Family
ID=20289060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03797759A Expired - Lifetime EP1549391B1 (en) | 2002-09-23 | 2003-06-23 | Implantable medical device |
Country Status (5)
Country | Link |
---|---|
US (1) | US7212863B2 (en) |
EP (1) | EP1549391B1 (en) |
DE (1) | DE60327090D1 (en) |
SE (1) | SE0202803D0 (en) |
WO (1) | WO2004026395A1 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7460912B2 (en) * | 2004-11-19 | 2008-12-02 | Cardiac Pacemakers, Inc. | System and method for temporary programming for implanted medical devices |
US8014867B2 (en) * | 2004-12-17 | 2011-09-06 | Cardiac Pacemakers, Inc. | MRI operation modes for implantable medical devices |
US8224443B2 (en) * | 2007-05-08 | 2012-07-17 | Cardiac Pacemakers, Inc. | Method for controlling pacemaker therapy |
US8032228B2 (en) | 2007-12-06 | 2011-10-04 | Cardiac Pacemakers, Inc. | Method and apparatus for disconnecting the tip electrode during MRI |
US8086321B2 (en) | 2007-12-06 | 2011-12-27 | Cardiac Pacemakers, Inc. | Selectively connecting the tip electrode during therapy for MRI shielding |
EP2231271B1 (en) | 2007-12-12 | 2016-06-22 | Cardiac Pacemakers, Inc. | Implantable medical device with hall sensor |
DE102008003440A1 (en) * | 2008-01-07 | 2009-07-09 | Kuka Roboter Gmbh | Method for error detection in a control system of a medical treatment and / or diagnostic device |
US8311637B2 (en) | 2008-02-11 | 2012-11-13 | Cardiac Pacemakers, Inc. | Magnetic core flux canceling of ferrites in MRI |
US8160717B2 (en) | 2008-02-19 | 2012-04-17 | Cardiac Pacemakers, Inc. | Model reference identification and cancellation of magnetically-induced voltages in a gradient magnetic field |
US8571661B2 (en) | 2008-10-02 | 2013-10-29 | Cardiac Pacemakers, Inc. | Implantable medical device responsive to MRI induced capture threshold changes |
EP2398553B1 (en) | 2009-02-19 | 2015-07-22 | Cardiac Pacemakers, Inc. | Systems for providing arrhythmia therapy in mri environments |
US9174058B2 (en) | 2009-09-29 | 2015-11-03 | Medtronic, Inc. | Automatic selection of parameters of an exposure mode of an implantable medical device |
US8260422B2 (en) * | 2009-10-19 | 2012-09-04 | Medtronic, Inc. | Implantable medical device with selectively configurable exposure operating mode programming options |
US8165691B2 (en) * | 2009-10-19 | 2012-04-24 | Medtronic, Inc. | Implantable medical device with selectively configurable exposure operating mode programming options |
US9205268B2 (en) * | 2009-10-30 | 2015-12-08 | Medtronic, Inc. | Configuring operating parameters of a medical device based on a type of source of a disruptive energy field |
US9958515B2 (en) * | 2009-10-30 | 2018-05-01 | Medtronic, Inc. | Configuring operating parameters of a medical device based on a type of source of a disruptive energy field |
EP2498866B1 (en) * | 2009-11-10 | 2017-05-24 | MED-EL Elektromedizinische Geräte GmbH | Implant power control |
WO2011071597A1 (en) | 2009-12-08 | 2011-06-16 | Cardiac Pacemakers, Inc. | Implantable medical device with automatic tachycardia detection and control in mri environments |
US9919158B2 (en) * | 2009-12-29 | 2018-03-20 | Medtronic, Inc. | Configuring operating parameters of a medical device based on exposure to a disruptive energy field |
US20110196450A1 (en) * | 2010-02-10 | 2011-08-11 | Medtronic, Inc. | Electronic prescription activation device |
US9724520B2 (en) | 2014-01-30 | 2017-08-08 | Medtronic, Inc. | Methods, implantable medical devices, and systems to continue implementing a special mode of operation after experiencing a device reset |
US9399140B2 (en) | 2014-07-25 | 2016-07-26 | Medtronic, Inc. | Atrial contraction detection by a ventricular leadless pacing device for atrio-synchronous ventricular pacing |
US9913988B2 (en) * | 2015-02-27 | 2018-03-13 | Medtronic, Inc. | Systems, apparatus, methods and computer-readable storage media facilitating telemetry with an implantable device |
US11957635B2 (en) | 2015-06-20 | 2024-04-16 | Therabody, Inc. | Percussive therapy device with variable amplitude |
US10286209B2 (en) | 2016-04-29 | 2019-05-14 | Medtronic, Inc. | Methods and implantable medical devices for automatic entry to an exposure mode of operation upon exposure to a magnetic disturbance |
US11207527B2 (en) | 2016-07-06 | 2021-12-28 | Cardiac Pacemakers, Inc. | Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
US10729486B2 (en) * | 2016-08-23 | 2020-08-04 | Covidien Lp | Implant mode for electrosurgical generator |
US11890253B2 (en) | 2018-12-26 | 2024-02-06 | Therabody, Inc. | Percussive therapy device with interchangeable modules |
US11998504B2 (en) | 2019-05-07 | 2024-06-04 | Therabody, Inc. | Chair including percussive massage therapy |
US11813221B2 (en) | 2019-05-07 | 2023-11-14 | Therabody, Inc. | Portable percussive massage device |
JP2022551474A (en) * | 2019-10-08 | 2022-12-09 | セラボディ,インコーポレイティド | Networked anti-theft and multi-user synchronization system and method for percussion massage device |
US11857481B2 (en) | 2022-02-28 | 2024-01-02 | Therabody, Inc. | System for electrical connection of massage attachment to percussive therapy device |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4390020A (en) * | 1983-02-17 | 1983-06-28 | Medtronic, Inc. | Implantable medical device and power source depletion control therefor |
US4875483A (en) * | 1983-10-17 | 1989-10-24 | Telectronics, N.V. | Implantable cardiac pacer with programmable antitachycardia mechanisms |
US4944298A (en) * | 1989-05-23 | 1990-07-31 | Siemens-Pacesetter, Inc. | Atrial rate based programmable pacemaker with automatic mode switching means |
US5292342A (en) * | 1992-05-01 | 1994-03-08 | Medtronic, Inc. | Low cost implantable medical device |
US5722998A (en) * | 1995-06-07 | 1998-03-03 | Intermedics, Inc. | Apparatus and method for the control of an implantable medical device |
US6216038B1 (en) * | 1998-04-29 | 2001-04-10 | Medtronic, Inc. | Broadcast audible sound communication of programming change in an implantable medical device |
US6370432B1 (en) * | 1999-08-20 | 2002-04-09 | Cardiac Pacemakers, Inc. | Pacemaker passive measurement testing system and method |
US6424867B1 (en) * | 1999-09-30 | 2002-07-23 | Pacesetter, Inc. | Secure telemetry system and method for an implantable cardiac stimulation device |
-
2002
- 2002-09-23 SE SE0202803A patent/SE0202803D0/en unknown
-
2003
- 2003-06-23 US US10/528,671 patent/US7212863B2/en not_active Expired - Lifetime
- 2003-06-23 DE DE60327090T patent/DE60327090D1/en not_active Expired - Lifetime
- 2003-06-23 EP EP03797759A patent/EP1549391B1/en not_active Expired - Lifetime
- 2003-06-23 WO PCT/SE2003/001082 patent/WO2004026395A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP1549391A1 (en) | 2005-07-06 |
US7212863B2 (en) | 2007-05-01 |
DE60327090D1 (en) | 2009-05-20 |
WO2004026395A1 (en) | 2004-04-01 |
US20060074455A1 (en) | 2006-04-06 |
SE0202803D0 (en) | 2002-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1549391B1 (en) | Implantable medical device | |
EP0931566B1 (en) | Interference detecting pacemaker | |
EP0363015B1 (en) | Rate stabilization pacemaker | |
EP0902709B1 (en) | Arrhythmia and fibrillation prevention pacemaker using consistent pacing | |
US5607459A (en) | Implantable cardiac stimulation device with time-of-day selectable warning system | |
EP0774274B1 (en) | Pacemaker with automatic blanking period function | |
US5722998A (en) | Apparatus and method for the control of an implantable medical device | |
US7272433B2 (en) | Transcutaneous monitor and method of use, using therapeutic output from an implanted medical device | |
US6324427B1 (en) | Implantable cardiac stimulation device having T-wave discrimination of fusion events during autocapture/autothreshold assessment | |
EP0496865B1 (en) | Dual chamber rate responsive pacemaker | |
US20120265263A1 (en) | Medical Device Sensing and Detection During MRI | |
EP0536720A1 (en) | System for terminating a pacemaker-mediated tachycardia during rate adaptive pacing | |
EP0719569A2 (en) | Autothreshold assessment in an implantable pacemaker | |
EP0646390A1 (en) | Heart stimulator | |
EP0657186B1 (en) | Cardiac pacemaker with triggered magnet modes | |
US7058448B2 (en) | Dual chamber pacing system with a mode switch | |
EP0058603B1 (en) | Implantable medical device power source depletion indicators | |
WO2001005465A1 (en) | Pacemaker | |
EP1684856B1 (en) | Device for adjusting the sensitivity level of an implantable medical device | |
US8649877B2 (en) | Extended noise mode | |
Greenspon et al. | " Pseudo" loss of atrial sensing by a DDD pacemaker. | |
US6799071B2 (en) | Method and apparatus for safely disabling runaway pacing protection in a cardiac rhythm management device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050425 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
RBV | Designated contracting states (corrected) |
Designated state(s): CH DE FR IE IT LI |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): CH DE FR IE IT LI |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: CH Ref legal event code: NV Representative=s name: E. BLUM & CO. AG PATENT- UND MARKENANWAELTE VSP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60327090 Country of ref document: DE Date of ref document: 20090520 Kind code of ref document: P |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20100111 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20100226 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090630 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090623 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090408 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20140627 Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150630 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150630 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20200518 Year of fee payment: 18 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60327090 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220101 |